GLP-1, Chronic Kidney Disease
The future of healthcare is defined by this blend of technology and human expertise, offering new hope for a more efficient ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
Since kidney disease often progresses without noticeable symptoms in the early stages, its important to stay vigilant and ...
Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...
When Mrs Jennie Tan was diagnosed with end-stage kidney disease, her husband made a decision that gave her a second chance at ...
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
Chronic health conditions are having a serious, negative impact on the welfare of the country's workers and their output, a ...
This model exhibits ... New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results